Skip to main content

Table 2 Postoperative characteristics and resource utilization of the patient groups

From: Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial

Characteristics Propofol (n = 44) Dexmedetomidine (n = 44) P value
AF during 96 h after surgery 16 (36.4) 6 (13.6) 0.025
Onset of AF (h after operation) 25.5 (19.5–36.4) 40.4 (19.3–53.1) 0.261
In-hospital mortality 1 (2.3) 0 (0) >0.999
Mortality during study period 1 (2.3) 0 (0) >0.999
Serum potassium before AF, mmol/L 4.2 (3.9–4.3) 4.0 (3.–4.1) 0.083
Peak postoperative cTnI, ng/mL 5.5 (2.9–9.5) 6.9 (2.6–11.8) 0.611
Hypotension 13 (29.5) 25 (56.8) 0.017
Bradycardia 1 (2.3) 4 (9.1) 0.360
Nausea/vomiting 10 (22.7) 9 (20.5) >0.999
Delirium 5 (11.4) 0 (0) 0.055
Acute kidney injury 3 (6.8) 5 (11.4) 0.713
Mechanical ventilation ≥24 h 6 (13.6) 4 (9.1) 0.739
Intubation time, h 21.2 (17.0–22.8) 21.0 (16.9–22.5) 0.757
Length of ICU stay, days 3.5 (2.7–4.5) 2.9 (2.4–3.5) 0.008
Length of hospital stay, days 14.0 (11.0–17.0) 13.5 (11.3–17.0) 0.983
Postoperative hospital days 8.0 (7.0–10.0) 8.0 (7.0–9.8) 0.505
Hospital fees, Chinese yuan, ×104 8.64 (7.32–9.63) 7.79 (6.72–9.05) 0.068
  1. Data are presented as the number (%) or median (interquartile range). AF atrial fibrillation, cTnI cardiac troponin I, ICU intensive care unit